Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginseng augmentation for opioid withdrawal symptoms
IRCT201009063106N4Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ginseng in opioid withdrawal, sponsored by Islamic Azad University. Primary endpoint: Intensity of opioid withdrawal symptoms. Started Jul 2009; status: completed.
02
Drugs
ginseng
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on IRCT201009063106N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201009063106N4.